Initial assessment for patients with HIV: Difference between revisions

From IDWiki
(Imported from text file)
 
No edit summary
 
(10 intermediate revisions by the same user not shown)
Line 1: Line 1:
 
==History==
= HIV: First clinic visit =
 
   
 
*Date and context of diagnosis
== History ==
 
  +
*History of [[Opportunistic infections in HIV]]
 
*Sexual history
   
 
==Investigations==
* Date and context of diagnosis
 
* History of [HIV opportunistic infections](../Complications/Opportunistic infections/Opportunistic infections.md)
 
* Sexual history
 
   
 
*HIV-specific
== Investigations ==
 
 
**CD4/CD8 count
 
**HIV-RNA viral load
  +
**HIV genotype
 
**HLA *B5701 genotyping (for abacavir)
  +
**Genetic resistance assays (± tropism testing for CCR5 inhibitors)
 
**G6PD deficiency
 
*Routine
 
**CBC, lytes, creatinine
 
**Fasting lipids, Hb A1c
 
**Urinalysis (glucose and protein)
  +
**Consider bone mineral density testing and vitamin D levels
 
*STIs and coinfections
  +
**TB skin test
  +
**Consider chest x-ray
  +
**HAV-IgG, HBV-sAg/sAb/cAb, and HCV-Ab
 
**Syphilis
 
**Three-site mucosal (genital/rectal/throat) NAAT for chlamydia and gonorrhea
 
**Toxoplasma, varicella, CMV, and measles serologies
  +
*For cis women and trans men
  +
**Pap smear
  +
**Rubella serology
  +
**Trichomonas testing
  +
*Low threshold for CT chest/abdo/pelvis for lymphadenopathy and non-tuberculous mycobacteria in patients with low CD4 counts
   
  +
== Physical Examination ==
* HIV-specific
 
** CD4 count
 
** HIV-RNA viral load
 
** HLA B5701 genotyping (for abacavir)
 
** Genetic resistance assays
 
** G6PD deficiency
 
* STIs and coinfections
 
** Hepatitis A, B, and C serologies
 
** Syphilis
 
** Three-site mucosal (genital/rectal/throat) NAAT for chlamydia and gonorrhea
 
* Routine
 
** CBC, lytes, creatinine
 
** Fasting lipids
 
** Urinalysis (glucose and protein)
 
   
  +
* Assess for cutaneous Kaposi sarcoma
== Initial regimens ==
 
   
 
==Initial Regimens==
* All are integrase inhibitor with two nucleoside analogues
 
  +
* Consider one of the [HIV single-tablet regimens](Single-tablet regimens.md)
 
 
*All are integrase inhibitor with two nucleoside analogues
** Triumeq (if HLA B5701 negative): dolutegravir, abacavir, and lamivudine
 
 
*Consider one of the [[single-tablet regimens for HIV]]
** Truvada (tenofovir/TDF and emtricitabine) with either dolutegravir or raltegravir
 
  +
**Biktarvy 1 tablet PO once daily
** Stribild: elvitegravir/cobicistat/tenofovir disoproxil/emtricitabine
 
 
**Triumeq (if HLA B5701 negative): dolutegravir, abacavir, and lamivudine
** Complera: emtricitabine/rilpivirine/tenofovir disoproxil
 
 
**Truvada (tenofovir/TDF and emtricitabine) with either dolutegravir or raltegravir
 
**Stribild: elvitegravir/cobicistat/tenofovir disoproxil/emtricitabine
 
**Complera: emtricitabine/rilpivirine/tenofovir disoproxil
  +
*Don't forget to add [[TMP-SMX]] DS 1 tablet PO daily if presumed low CD4 count
  +
  +
==Further Reading==
  +
  +
*[http://occguidelines.com/guidelines/ Clinical Care Guidelines for Adults and Adolescents Living with HIV in Ontario, Canada]
  +
*Primary Care Guidelines for the Management of Persons Infected With HIV: 2013 Update. ''Clin Infect Dis''. 2014:58(1):e1–e34. doi: [https://doi.org/10.1093/cid/cit665 10.1093/cid/cit665]
  +
  +
[[Category:HIV]]

Latest revision as of 11:10, 30 April 2021

History

Investigations

  • HIV-specific
    • CD4/CD8 count
    • HIV-RNA viral load
    • HIV genotype
    • HLA *B5701 genotyping (for abacavir)
    • Genetic resistance assays (± tropism testing for CCR5 inhibitors)
    • G6PD deficiency
  • Routine
    • CBC, lytes, creatinine
    • Fasting lipids, Hb A1c
    • Urinalysis (glucose and protein)
    • Consider bone mineral density testing and vitamin D levels
  • STIs and coinfections
    • TB skin test
    • Consider chest x-ray
    • HAV-IgG, HBV-sAg/sAb/cAb, and HCV-Ab
    • Syphilis
    • Three-site mucosal (genital/rectal/throat) NAAT for chlamydia and gonorrhea
    • Toxoplasma, varicella, CMV, and measles serologies
  • For cis women and trans men
    • Pap smear
    • Rubella serology
    • Trichomonas testing
  • Low threshold for CT chest/abdo/pelvis for lymphadenopathy and non-tuberculous mycobacteria in patients with low CD4 counts

Physical Examination

  • Assess for cutaneous Kaposi sarcoma

Initial Regimens

  • All are integrase inhibitor with two nucleoside analogues
  • Consider one of the single-tablet regimens for HIV
    • Biktarvy 1 tablet PO once daily
    • Triumeq (if HLA B5701 negative): dolutegravir, abacavir, and lamivudine
    • Truvada (tenofovir/TDF and emtricitabine) with either dolutegravir or raltegravir
    • Stribild: elvitegravir/cobicistat/tenofovir disoproxil/emtricitabine
    • Complera: emtricitabine/rilpivirine/tenofovir disoproxil
  • Don't forget to add TMP-SMX DS 1 tablet PO daily if presumed low CD4 count

Further Reading